Source: International Journal of Endocrinology. Unidade: ICB
Subjects: HISTOLOGIA, INSULINA (RESISTÊNCIA), CAMUNDONGOS, RATOS WISTAR
ABNT
PROTZEK, André O. P. et al. Augmented β-Cell function and mass in glucocorticoid-treated rodents are associated with increased islet Ir-β/AKT/mTOR and decreased AMPK/ACC and AS160 signaling. International Journal of Endocrinology, v. 2014, p. 1-14, 2014Tradução . . Disponível em: https://doi.org/10.1155/2014/983453. Acesso em: 31 ago. 2024.APA
Protzek, A. O. P., Costa-Júnior, J. M., Rezende, L. F., Santos, G. J., Araújo, T. G., Vettorazzi, J. F., et al. (2014). Augmented β-Cell function and mass in glucocorticoid-treated rodents are associated with increased islet Ir-β/AKT/mTOR and decreased AMPK/ACC and AS160 signaling. International Journal of Endocrinology, 2014, 1-14. doi:10.1155/2014/983453NLM
Protzek AOP, Costa-Júnior JM, Rezende LF, Santos GJ, Araújo TG, Vettorazzi JF, Ortis F, Carneiro EM, Rafacho A, Boschero AC. Augmented β-Cell function and mass in glucocorticoid-treated rodents are associated with increased islet Ir-β/AKT/mTOR and decreased AMPK/ACC and AS160 signaling [Internet]. International Journal of Endocrinology. 2014 ; 2014 1-14.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1155/2014/983453Vancouver
Protzek AOP, Costa-Júnior JM, Rezende LF, Santos GJ, Araújo TG, Vettorazzi JF, Ortis F, Carneiro EM, Rafacho A, Boschero AC. Augmented β-Cell function and mass in glucocorticoid-treated rodents are associated with increased islet Ir-β/AKT/mTOR and decreased AMPK/ACC and AS160 signaling [Internet]. International Journal of Endocrinology. 2014 ; 2014 1-14.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1155/2014/983453